168 related articles for article (PubMed ID: 34160411)
1. Donafenib treatment for hepatocellular carcinoma: A case report.
Li Q; Zhu H
Medicine (Baltimore); 2021 Jun; 100(25):e26373. PubMed ID: 34160411
[TBL] [Abstract][Full Text] [Related]
2. Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial.
Qin S; Bi F; Gu S; Bai Y; Chen Z; Wang Z; Ying J; Lu Y; Meng Z; Pan H; Yang P; Zhang H; Chen X; Xu A; Cui C; Zhu B; Wu J; Xin X; Wang J; Shan J; Chen J; Zheng Z; Xu L; Wen X; You Z; Ren Z; Liu X; Qiu M; Wu L; Chen F
J Clin Oncol; 2021 Sep; 39(27):3002-3011. PubMed ID: 34185551
[TBL] [Abstract][Full Text] [Related]
3. Successful management of the hepatocellular carcinoma with inferior vena cava tumor thrombus: A case report.
Liu Y; Xie K; Li J; Wang Z; Zeng Y; Wu H
Medicine (Baltimore); 2021 May; 100(21):e26081. PubMed ID: 34032742
[TBL] [Abstract][Full Text] [Related]
4. Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
Tohyama T; Sakamoto K; Tamura K; Nakamura T; Watanabe J; Wakisaka H; Takada Y
World J Surg Oncol; 2020 May; 18(1):109. PubMed ID: 32466780
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of mortality in the patients with hepatocellular carcinoma: A multicenter study in Indonesia.
Jasirwan COM; Hasan I; Sulaiman AS; Lesmana CRA; Kurniawan J; Kalista KF; Nababan SH; Gani RA
Curr Probl Cancer; 2020 Feb; 44(1):100480. PubMed ID: 31130257
[TBL] [Abstract][Full Text] [Related]
6. Safety, pharmacokinetics and efficacy of donafenib in treating advanced hepatocellular carcinoma: report from a phase 1b trial.
Liu J; Li X; Zhang H; Chen G; Chen H; Hu Y; Niu J; Ding Y
Pharmazie; 2019 Nov; 74(11):688-693. PubMed ID: 31739839
[No Abstract] [Full Text] [Related]
7. Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
Vagefi PA; Hirose R
J Gastrointest Cancer; 2010 Dec; 41(4):217-20. PubMed ID: 20443078
[TBL] [Abstract][Full Text] [Related]
8. Current management of hepatocellular carcinoma.
Mendizabal M; Reddy KR
Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
[TBL] [Abstract][Full Text] [Related]
9. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
10. Review article: the management of hepatocellular carcinoma.
Cabrera R; Nelson DR
Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma.
Daoudaki M; Fouzas I
Wien Med Wochenschr; 2014 Nov; 164(21-22):450-5. PubMed ID: 25182146
[TBL] [Abstract][Full Text] [Related]
13. Management of HCC.
de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
[TBL] [Abstract][Full Text] [Related]
14. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
[TBL] [Abstract][Full Text] [Related]
15. Donafenib: First Approval.
Keam SJ; Duggan S
Drugs; 2021 Nov; 81(16):1915-1920. PubMed ID: 34591285
[TBL] [Abstract][Full Text] [Related]
16. Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy.
Park JG; Park SY; Lee HW
World J Gastroenterol; 2015 Feb; 21(8):2568-72. PubMed ID: 25741170
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Donafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma in China.
Guan H; Wang C; Zhao Z; Han S
Adv Ther; 2022 Jul; 39(7):3334-3346. PubMed ID: 35644019
[TBL] [Abstract][Full Text] [Related]
18. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.
Chong CC; Wong GL; Lai PB
World J Gastroenterol; 2014 May; 20(20):6006-12. PubMed ID: 24876723
[TBL] [Abstract][Full Text] [Related]
19. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.
Rastogi A
World J Gastroenterol; 2018 Sep; 24(35):4000-4013. PubMed ID: 30254404
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.
Kim SU; Seo YS; Lee HA; Kim MN; Lee EJ; Shin HJ; Lee YR; Lee HW; Park JY; Kim DY; Ahn SH; Han KH; Um SH; Tak WY; Kweon YO; Kim BK; Park SY
Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):832-837. PubMed ID: 31988073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
